Mti-105
ClinicalTrials.gov NCT03546816
Research payments
$588,070
Through program year 2020, $588,070 in research payments was reported against Mti-105, across 327 payments, paid by VYNE Pharmaceuticals Inc..
- Paid by
- VYNE Pharmaceuticals Inc.
- ClinicalTrials.gov
- NCT03546816
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $588,070 | 327 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ellen Frankel Cranston, RI Named on 29 payments
- Blakely Richardson Austin, TX Named on 13 payments
- Valerie Callender Glenn Dale, MD Named on 12 payments
- Laura Ferris Pittsburgh, PA Named on 12 payments
- Jennifer Soung Santa Ana, CA Named on 11 payments
- Matthew Zirwas Bexley, OH Named on 11 payments
- Sarah Jackson New Orleans, LA Named on 11 payments
- Sunil Dhawan Fremont, CA Named on 11 payments
- Zelma Chiesa Fuxench Philadelphia, PA Named on 10 payments
- Johnnie Woodson Henderson, NV Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.